Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

2.0%

3 terminated/withdrawn out of 152 trials

Success Rate

94.9%

+8.3% vs industry average

Late-Stage Pipeline

11%

16 trials in Phase 3/4

Results Transparency

1 of 56 completed trials have results

Key Signals

34 recruiting1 with results

Enrollment Performance

Analytics

N/A

56(68.3%)

Phase 4

10(12.2%)

Phase 2

8(9.8%)

Phase 3

6(7.3%)

Early Phase 1

1(1.2%)

Phase 1

1(1.2%)

82Total

N/A(56)

Phase 4(10)

Phase 2(8)

Phase 3(6)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (152)

Showing 20 of 152 trials

NCT07855679Recruiting

Pulmonary Embolism Registry From Emergency to Long-Term Follow-Up and Surveillance

Role: collaborator

NCT07718048Not ApplicableRecruiting

Acute Effects of MCT Formulations on Beta-Hydroxybutyrate Response, Lipid Profile, and Glucose Levels in Healthy Adults

Role: collaborator

NCT03766321Not ApplicableCompleted

Fecal Microbiota Transplantation Effect on Amyotrophic Lateral Sclerosis Patients

Role: collaborator

NCT07131371Active Not Recruiting

Stratification, Management, and Guidance of Hypertrophic Cardiomyopathy Patients Using Hybrid Digital Twin Solutions

Role: collaborator

NCT07731334Not ApplicableRecruiting

Prevalence of Mild Cognitive Impairment and Dementia in Patients Admitted to Non-neurological Rehabilitation Wards

Role: collaborator

NCT07747272Recruiting

Nerve-SPARing Robotic Prostatectomy: The Impact of Patient Baseline Profiles on Erectile Function

Role: lead

NCT07681466Recruiting

Chronology and Sequence of Premonitory Symptoms

Role: collaborator

NCT06409845Completed

Effectiveness and Tolerability of Eptinezumab

Role: lead

NCT06409832Recruiting

RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment

Role: lead

NCT07629700Not ApplicableNot Yet Recruiting

Study of Peripheral Neuropathy in Patients With Advanced Urothelial Cancer Treated With Enfortumab Vedotin and Pembrolizumab With Supportive Neuridase (ENDEAVOR)

Role: lead

NCT07622537Not Yet Recruiting

Late Effects of Cancer Therapies on Gonadal Function, Fertility, Efficiency of Fertility Preservation Procedures and Pregnancy Outcomes

Role: collaborator

NCT07612943Not Yet Recruiting

ProspectiveMaleAYA - Frequency and Prediction of Therapy-induced Testicular Dysfunction in AYA Cancer Survivors

Role: collaborator

NCT06747429Not ApplicableRecruiting

High Fat Diet for Cardiac Metabolic Reprogramming

Role: collaborator

NCT04806906Phase 2Completed

Pilot Study of CC 486 (Oral Azacitidine) Plus BSC as Maintenance After sc Azacitidine in Elderly HR-IPSS-R MDS Patients

Role: lead

NCT03404336Not ApplicableRecruiting

Study on 30 Outpatients With Chronic Migraine Treated With Well-Being Therapy or With a Control Therapy

Role: lead

NCT06135753Not ApplicableRecruiting

Psychosomatic Intervention in Fibromyalgia.

Role: lead

NCT07404410Not ApplicableRecruiting

Robotic Technologies for APATHy in Dementia: a Randomised Controlled Trial (RAPHAel)

Role: collaborator

NCT07251517Not ApplicableCompleted

Cognitive Rehabilitation in Post-stroke Cognitive Impairment

Role: lead

NCT06403631Completed

Supporting Mental Health in Daily Life After the Diagnosis of Multiple Sclerosis

Role: collaborator

NCT06797050Not ApplicableRecruiting

A Story for Pepper & Nao

Role: collaborator